Akers BioSciences Regains Compliance with Nasdaq Listing Standards
11 déc. 2019 09h30 HE
|
Akers Biosciences Inc.
Thorofare, New Jersey, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, announced today that on...
Akers BioSciences, Inc. Announces Closing of Approximately $8 Million Public Offering
09 déc. 2019 11h40 HE
|
Akers Biosciences Inc.
Thorofare, New Jersey, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company” or “we”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced the...
Akers Biosciences to Attend Hemp Industry Daily Forum in Las Vegas, Nevada
06 déc. 2019 09h30 HE
|
Akers Biosciences Inc.
Thorofare, New Jersey, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that Executive...